IL4 and neoplasm: The M1 population is thought to be beneficial in a tumor environment (including solid tumors and circulating tumor cells) but this environment is overwhelmed by anti-inflammatory signals, and type-II cytokines (e.g. IL-4, IL-10 and IL-13) tend to dominate (Supplementary Figure S3) [29–32].